Study to assess the role of rifaximin in glycaemic control of poorly controlled diabetics.
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- SLCTR/2018/004
- Lead Sponsor
- Faculty of Medicine, University of Kelaniya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1. Male and female patients aged between 18-80 years
2. Type 2 diabetes for more than 5 years with last HbA1c done within three months of recruitment of more than 8%
Exclusion Criteria
1. Patients with known allergies to rifaximin.
2. Patients who have taken any antibiotic within three months prior to the recruitment.
3. Patients who are on continuous proton pump inhibitors for more than one month duration at the time of recruitment
4. Patients who are on concurrent vitamin supplements at the time of recruitment.
5. Patients who have chronic lower gastro intestinal symptoms at the time of recruitment.
6. Patients who are pregnant or lactating
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycaemic control assessed by reduction in HbA1c value >1% and/or reduction in post-prandial blood glucose (PPBG) >10% from baseline [HbA1C: At baseline and at the end of three months after the commencement of the intervention<br><br>PPBG: At baseline, and at the end of two weeks and four weeks after the commencement of the intervention]<br>
- Secondary Outcome Measures
Name Time Method one [None]<br>